Trial intelligence / Profile preview

APIS: Apixaban for Intrahepatic Non-Cirrhotic Portal Hypertension

2024-514348-95-00Phase 3Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Portal Fibrosis and portal vein thrombosis (PVT) comparing Eliquis (apixaban) arm with Placebo arm (2 arms). Started Jul 2024; status: completed.

02

Drugs

apixaban
03

Conditions

Portal Fibrosisportal vein thrombosis (PVT)

Beyond the preview

Go deeper on 2024-514348-95-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-514348-95-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call